مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

14,927
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARISON OF SULFASALASIN AND MESALAMIN AND THEIR SIDE EFFECTS IN ACUTE PHASE OF ULCERATIVE COLITIS

Pages

  5-11

Abstract

 Background and Objectives: SULFASALASIN (SAZ) is the main drug of choice for the treatment of ULCERATIVE COLITIS (UC). Existing sulfafyridin in SULFASALASIN is nost therapeutically effective, however it is responsible for 5 - Aminosalicylic acid transport and its side effect. Keeping the therapeutical effects of drug, sulfapyridin has been omitted from MESALAMIN (MZ) to omit its side effects. Regarding MESALAMIN’s high cost, present study was conducted for the comparison of the effects and side effects of these two drugs in treating UC to clarify the cost - effectiveness of each drug.Materials and Methods: A total fourty patients with UC, who had the same severity of disease on the basis of clinical, laboratory, endoscopic and histologic findings and based on scoring, were treated randomly with SAZ or MZ. They underwent clinical examination after 2 and 6 weeks of therapy, followed up by clinical and endoscopic examination after 3 months. Results: Disease severity index in MZ group decreased from 15.1 (SD=3.4) at admission time to 6.9 (SD=5.6) 3 months after therapy, and in SAZ group from 14.4 (SD=4.4) to 4.6 (SD=4.7), that is, both drugs caused improvement in the severity of disease (p<0.0001). However, the comparison of the response to drugs in two groups didn’t show any significant difference (p>0.16). Few and mild side effects were observed in SAZ group.Conclusion: Therapeutic response of SULFASALASIN and MESALAMIN in the therapy of UC is the same, however SULFASALASINs side effects are few and mild.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    BAFANDEH, Y., MASARAT, S., ESMAEILI, H., & FATTAHI, E.B.. (2002). COMPARISON OF SULFASALASIN AND MESALAMIN AND THEIR SIDE EFFECTS IN ACUTE PHASE OF ULCERATIVE COLITIS . MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES, -(54), 5-11. SID. https://sid.ir/paper/47444/en

    Vancouver: Copy

    BAFANDEH Y., MASARAT S., ESMAEILI H., FATTAHI E.B.. COMPARISON OF SULFASALASIN AND MESALAMIN AND THEIR SIDE EFFECTS IN ACUTE PHASE OF ULCERATIVE COLITIS . MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2002;-(54):5-11. Available from: https://sid.ir/paper/47444/en

    IEEE: Copy

    Y. BAFANDEH, S. MASARAT, H. ESMAEILI, and E.B. FATTAHI, “COMPARISON OF SULFASALASIN AND MESALAMIN AND THEIR SIDE EFFECTS IN ACUTE PHASE OF ULCERATIVE COLITIS ,” MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF MEDICAL SCIENCES, vol. -, no. 54, pp. 5–11, 2002, [Online]. Available: https://sid.ir/paper/47444/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button